IPO News and Updates

8/1/14


Otonomy, a late-stage biotech developing sustained-exposure treatments for ear diseases, announced terms for its IPO on Friday. The San Diego, CA-based company plans to raise $80 million by offering 5.3 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Otonomy would command a fully diluted market value of $315 million.

Otonomy's lead candidate treats middle ear effusion developed during tympanostomy tube placement surgery. The company plans to submit an NDA in the 1H15. Its IPO follows Auris Medical (EARS), another ear-related biotech scheduled to begin trading next week. Otonomy is in Phase 2 trials for Ménière’s Disease and preclinical studies for tinnitus, both of which are targeted by Auris.

Otonomy, which was founded in 2008, plans to list on the NASDAQ under the symbol OTIC. J.P. Morgan and BofA Merrill Lynch are the joint bookrunners on the deal. It is expected to price during the week of August 11, 2014.


Keywords: OTIC, EARS, Biotech

8/1/14


FCB Financial Holdings, a Florida-based bank formed through acquisitions of eight failed banks, raised $165 million by offering 7.5 million shares (39% from insiders) at $22, the low end of the range of $22-$23. The company had originally planned to sell 8.715 million shares (50% from insiders) at $24-$27 before reducing the insider selling component and cutting the range on Thursday. FCB Financial Holdings plans to list on the NYSE under the symbol FCB. Deutsche Bank, J.P. Morgan, BofA Merrill Lynch and UBS acted as lead managers on the deal.


Keywords: FCB

8/1/14


Mobileye, an Israeli developer of camera-based Advanced Driver Assistance Systems (ADAS), raised $890 million by offering 35.6 million shares (77% insider) at $25, well above the upwardly revised range of $21 to $23. Mobileye plans to list on the NYSE under the symbol MBLY. Mobileye initially filed confidentially on 5/12/2014. Goldman Sachs, Morgan Stanley, Deutsche Bank, Barclays and Citi acted as joint bookrunners on the deal.


Keywords: MBLY

8/1/14


VTTI Energy Partners LP, an MLP formed by VTTI to own refined product and crude oil terminals, raised $368 million by offering 17.5 million shares (all sold by the parent) at $21, the high end of the range of $19 to $21. VTTI Energy Partners LP plans to list on the NYSE under the symbol VTTI. Citi, J.P. Morgan, BofA Merrill Lynch, Credit Suisse, Deutsche Bank and Wells Fargo were the bookrunners on the deal.


Keywords: VTTI

Archived News Headlines
Attribution Policy: The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: IPO investment firm Renaissance Capital (www.renaissancecapital.com).
Performance Disclosure: Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.

As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund’s average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees. An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.

Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds. The Renaissance IPO Index® (IPOUSA) is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The S&P 500® Index (SPX) is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE. The S&P 500 index components are determined by S&P Dow Jones Indices.

Risk Disclosure: Investments in the Renaissance IPO ETF, symbol "IPO" (the “ETF”) and the Global IPO Fund, symbol "IPOSX" (the “Mutual Fund”) are subject to investment risk, including possible loss of the principal amounts invested. The ETF and the Mutual Fund (the “Funds”) invest in companies that have recently completed their initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. The Funds may also be subject to information technology risk and small and mid-capitalization company risk due to a greater number of IPOs in these sectors. The Funds may hold securities in the form of Depository Receipts, REITs, Master Limited Partnerships (MLPs) which have greater risks than common shares. The strategy has high portfolio turnover and securities lending risks. ETF returns may not match the return of the respective index. The ETF is classified as a non-diversified investment company and is subject to concentration risk.

Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with information about the Funds, please visit www.renaissancecapital.com. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETF, 1-866-486-6645.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX), may have investments in securities of companies mentioned.